Preventing Alloimmunization via RBC Antigen Matching

How can facilities prevent alloimmunization in patients—and control associated costs?

Nov 13, 2019

Duration: 17 minutes

Dr. Aaron Tobian reviews a cost-effectiveness study highlighting the health and financial implications of four alternative antigen matching strategies in a chronically transfused patient population often associated with extensive healthcare utilization and high lifetime costs. He examines the impact of increasing healthcare costs in transfusion medicine and the need for cost-effective alternative strategies to reduce alloimmunization.

Disclosures: This promotional educational activity is brought to you by Ortho Clinical Diagnostics and is not certified for Continuing Medical Education (CME). The speakers are presenting on behalf of Ortho Clinical Diagnostics and must present information in accordance with applicable and/or local regulatory country requirements.

About Our Speakers:
About Our Speakers:

Aaron Tobian, MD, PhD

Associate Professor of Pathology, Medicine and Epidemiology; Director, Transfusion Medicine - The Johns Hopkins University, Baltimore, MD